Category: Featured
National Securities Acts as Exclusive Financial Advisor to Interpace Diagnostics in $23.5M Acquisition of BioPharma Business
ORIGINAL PRESS RELEASE BELOW RE-POSTED FROM GLOBENEWSWIRE Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners PARSIPPANY NJ, July 15, 2019 (GLOBE NEWSWIRE) — Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) (“Interpace” or the “Company”), announced today that it has acquired assets and certain liabilities constituting the Biopharma Services business […]
Art Hogan’s Week in Review – July 12, 2019
July 12, 2019 The market saw two round numbers taken out, and all-time highs for the big three indexes. The Dow Jones Industrials took out the 27000 level ending the week at 27332. The S&P 500 found the 3000 milepost this week and was able to close at 3011, up 20% year-to-date. The Nasdaq closed […]
Art Hogan’s Week in Review – June 28, 2019
Week in Review The month of June ushered in the start of summer, along with the best month for US equities since January. Using linear logic, we would assume that all the months that start with the letter “J” will be good for markets. Bring on July! We actually saw the best June performance for […]
Art Hogan’s Week in Review – June 21, 2019
Week in review The S&P 500 closed at its first all-time high since April this week as markets focused on three big macro drivers: ECB’s Mario Draghi’s Dovish Speech; Presidents Trump and Xi’s phone call; and The FOMC’s dovish lean. In short the market has moved higher on the belief that Central banks will be […]
Art Hogan’s Week in Review – June 14, 2019
Week in Review After seven weeks of higher than normal volatility, the market settled into a relatively normal steady-as-she-goes pattern. Over the last seven weeks we had seen an 8% drawdown, followed by a 6% retracement higher. This past week had plenty of headlines, but none so shocking as to rock-the boat. The S&P 500 […]
Art Hogan’s Week in Review: May 24, 2019
Week in Review The growing concerns over the elongated US-China Trade war and its implications on the tech space, continues to weigh on stocks. The Dow Jones Industrial Average was down about 1% this week and posted its fifth consecutive weekly decline, its longest since 2011. The S&P 500 and Nasdaq Composite were down for […]